Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone versus placebo after final height in Prader-Willi syndrome
NL-OMON28633Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of somatropin in Prader-Willi syndrome (PWS) (2 arms), sponsored by Erasmus MC. Primary endpoints: Body composition, Carbohydrate metabolism and 7 more. Started Jun 2008; status: active, not recruiting.
02
Drugs
somatropin
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NL-OMON28633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28633.